Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Aclaris Therapeutics, Inc. | ACRS | 6.69M | $35.41M |
Trevi Therapeutics, Inc. | TRVI | 5.09M | $95.02M |
Erasca, Inc. | ERAS | 4.13M | $75.61M |
Editas Medicine, Inc. | EDIT | 3.56M | $11.52M |
Corvus Pharmaceuticals, Inc. | CRVS | 2.81M | $41.92M |
ORIC Pharmaceuticals, Inc. | ORIC | 1.85M | $20.02M |
ArriVent BioPharma, Inc. | AVBP | 1.68M | $58.44M |
Design Therapeutics, Inc. | DSGN | 1.61M | $23.34M |
Dyne Therapeutics, Inc. | DYN | 1.56M | $34.59M |
MoonLake Immunotherapeutics | MLTX | 1.4M | $27.26M |
Tango Therapeutics, Inc. | TNGX | 1.38M | $43.13M |
Aura Biosciences, Inc. | AURA | 1.17M | $8.28M |
LB Pharmaceuticals Inc Common Stock | LBRX | 800K | $25.96M |
Olema Pharmaceuticals, Inc. | OLMA | 671.84K | $8.4M |
Odyssey Therapeutics, Inc. | ODTX | 575K | $10.76M |
Abivax S.A. | ABVX | 414.9K | $55.29M |
Dianthus Therapeutics, Inc. | DNTH | 354K | $34.51M |
Praxis Precision Medicines, Inc. | PRAX | 271.12K | $90.77M |